Home
Gülen Arslan Lied's picture

Gülen Arslan Lied

Professor
  • E-mailGulen.Arslan@uib.no
  • Phone+47 55 97 30 58
  • Visitor Address
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
  • Postal Address
    Postboks 7804
    5020 Bergen

Professor 

Academic article
  • 2020. Supplementation with low doses of a cod protein hydrolysate on glucose regulation and lipid metabolism in adults with metabolic syndrome: A randomized, double-blind study. Nutrients. 1-15.
  • 2020. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome. Medicine.
  • 2020. Association between gastrointestinal complaints and psychopathology in patients with anorexia nervosa. International Journal of Eating Disorders. 532-536.
  • 2020. Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation . Gastroenterology Research and Practice. 1-9.
  • 2019. Supplementation with cod protein hydrolysate in older adults: A dose range cross-over study. Journal of Nutritional Science (JNS). 1-8.
  • 2019. Intraoperative anaphylaxis to gelatin-based hemostatic agents: a case report. Journal of Asthma and Allergy. 163-167.
  • 2019. Fish-derived proteins and their potential to improve human health. Nutrition reviews. 572-583.
  • 2019. Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome. Nutrients. 1-13.
  • 2019. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels. Scandinavian Journal of Gastroenterology. 690-699.
  • 2019. Acute effect of a cod protein hydrolysate on postprandial acylated ghrelin concentration and sensations associated with appetite in healthy subjects: a double-blind crossover trial. Food & Nutrition Research. 1-9.
  • 2018. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation. PLOS ONE. 1-17.
  • 2018. The effect of a controlled gluten challenge in a group of patients with suspected non-coeliac gluten sensitivity: A randomized, double-blind placebo-controlled challenge. Neurogastroenterology and Motility. 1-10.
  • 2018. Exploring gut microbiota composition as an indicator of clinical response to dietary FODMAP restriction in patients with irritable bowel syndrome. Digestive Diseases and Sciences. 429-436.
  • 2018. Effect of a cod protein hydrolysate on postprandial glucose metabolism in healthy subjects: A double-blind cross-over trial. Journal of Nutritional Science (JNS). 9 pages.
  • 2018. Does the low FODMAP diet improve symptoms of radiation-induced enteropathy? A pilot study. Scandinavian Journal of Gastroenterology. 541-548.
  • 2018. Altered levels of cytokines in patients with irritable bowel syndrome are not correlated with fatigue. International Journal of General Medicine. 285-291.
  • 2017. Red meat allergy induced by tick bites: A Norwegian case report. European Annals of Allergy and Clinical Immunology. 186-188.
  • 2017. Gastric accommodation in healthy subjects studied by ultrasound, manometry, and impedancemetry. Neurogastroenterology and Motility. 1-9.
  • 2017. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterology and Motility. 1-9.
  • 2016. Functional gastrointestinal symptoms are associated with higher serum total IgE levels, but less atopic sensitization. Digestive Diseases and Sciences. 189-197.
  • 2016. Extra-intestinal symptoms in patients with irritable bowel syndrome: related to high total IgE levels and atopic sensitization? Scandinavian Journal of Gastroenterology. 908-913.
  • 2014. Indication of immune activation in patients with perceived food hypersensitivity. Digestive Diseases and Sciences. 259-266.
  • 2013. Tetradecylthioacetic acid attenuates inflammation and has antioxidative potential during experimental colitis in rats. Digestive Diseases and Sciences. 97-106.
  • 2013. Forskningsveiledning - en av de essensielle faktorene på «veien til doktorgrad». UNIPED. 45-54.
  • 2012. Increased wall thickness using ultrasonography is associated with inflammation in an animal model of experimental colitis. Clinical and Experimental Gastroenterology. 195-201.
  • 2011. Subjective food hypersensitivity: assessment of enterochromaffin cell markers in blood and gut lavage fluid. International Journal of General Medicine. 555-560.
  • 2011. Dendritic cell populations in patients with self-reported food hypersensitivity. International Journal of General Medicine. 389-396.
  • 2010. Job stress and coping strategies in patients with subjective food hypersensitivity. Scandinavian Journal of Psychology. 179-184.
  • 2010. Intestinal B cell-activating factor: an indicator of non-IgE mediated hypersensitivity reactions to food? Alimentary Pharmacology and Therapeutics. 66-73.
  • 2010. Indications of 'atopic bowel' in patients with self-reported food hypersensitivity. Alimentary Pharmacology and Therapeutics. 1112-1122.
  • 2010. Duodenal administered seal oil for patients with subjective food hypersensitivity: an explorative open pilot study. International Journal of General Medicine. 383-392.
  • 2010. Do psychological factors predict symptom severity in patients with subjective food hypersensitivity? Scandinavian Journal of Gastroenterology. 835-843.
  • 2010. Anxiety and depression in patients with self-reported food hypersensitivity. General Hospital Psychiatry. 42-48.
  • 2009. Sonography of the small intestine. World Journal of Gastroenterology (WJG). 1319-1330.
  • 2009. Predictive value and clinical significance of myenteric plexitis in Crohn`s disease. Inflammatory Bowel Diseases. 1499-1507.
  • 2009. Clinical and surgical recurrence of Crohn`s diases after ileocolonic resection in a specialist unit. European Journal of Gastroenterology and Hepathology. 551-557.
  • 2008. Lifestyle of patients with self-reported food hypersensitivity differ little from controls. Gastroenterology Nursing. 401-410.
  • 2008. Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: A pilot study comparing seal oil and cod liver oil. Clinical Nutrition. 614-622.
  • 2008. Effects of seal oil on meal-induced symptoms and gastric accommodation in patients with subjective food hypersensitivity. A pilot study. Clinical Medicine : Gastroenterology. 33-41.
  • 2007. No Protection against DSS-induced Colitis by Short-term Pretreatment with Seal or Fish Oils in Rats. Integrative Medicine Insights. 25-34.
  • 2006. Short-term duodenal seal oil administration normalised n-6 to n-3 fatty acid ratio in rectal mucosa and ameliorated bodily pain in patients with inflammatory bowel disease. Lipids in Health and Disease.
  • 2006. Food Hypersensitivity Reactions Visualised by Ultrasonography and Magnetic Resonance Imaging in a Patient Lacking Systemic Food-Specific IgE. Digestion. 111-115.
  • 2005. Subjective health complaints and modern health worries in patients with subjective food hypersensitivity. Digestive Diseases and Sciences. 1245-1251.
  • 2005. Response to intestinal provocation monitored by transabdominal ultrasound in patients with food hypersensitivity. Scandinavian Journal of Gastroenterology. 386-394.
  • 2005. Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflammatory Bowel Diseases. 744-748.
  • 2005. Gastrointestinal matoverfølsomhet – et økende problem i befolkningen. Norsk Tidsskrift for Ernæring. 4-6.
  • 2005. Gastrointestinal matoverfølsomhet hos voksne - nye studier om mulige årsaker. Fagbladet Allergi i praksis. 12-17.
  • 2005. Food hypersensitivity-immunologic (peripheral) or cognitive (central) sensitisation? Psychoneuroendocrinology. 983-989.
  • 2005. Berstad A. Matoverfølsomhet hos voksne – nye studier om mulige årsaker. Fagbladet Allergi i praksis. 12-17.
  • 2005. An acute stressor enhances sensitivity to a chemical irritant and increases 51-CrEDTA permeability of the colon in adult rats. Integrative Physiological & Behavioral Science. 35-44.
  • 2004. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scandinavian Journal of Gastroenterology.
  • 2004. Quality of life in patients with subjective food hypersensitivity: Applicability of the 10-item short form of the Nepean Dyspepsia Index. Digestive Diseases and Sciences. 680-687.
  • 2004. Patients with subjective food hypersensitivity: The value of analysing intestinal permeability and inflammation markers in gut lavage fluid. Digestion. 26-35.
  • 2003. Intestinal permeability and faecal granulocyte marker protein in dextran sulphate sodium - induced colitis in rats. Scandinavian Journal of Laboratory Animal Science. 169-175.
  • 2002. Food allergy and intolerance: response to intestinal provocation monitored by endosonography. European Journal of Ultrasound. 29-36.
  • 2002. Effects of duodenal seal oil administration in patients with inflammatory bowel disease. Lipids. 935-940.
  • 2001. Serum eosinophilic cationic protein: A marker of eosinophilic infiltration in inflammatory bowel disease? The Turkish Journal of Gastroenterology. 136-140.
  • 2001. 51CrEDTA colonic permeability and therapy response in ulcerative colitis. Nuclear medicine communications. 997-1001.
  • 2000. Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid. Scandinavian Journal of Gastroenterology.
  • 2000. Assessment of intestinal permeability using 51CrEDTA in inflammatory bowel disease. The Turkish Journal of Gastroenterology. 320-325.
Lecture
  • 2018. IgE- and non-IgE-mediated enteropathies in adults.
  • 2018. Food hypersensitivity in adults.
  • 2017. Kasuistikk. Matvareallergi og matvareintoleranse.
  • 2017. Cøliaki og non-cøliakisk gluten intoleranse.
  • 2017. Allergic, IgE /non-IgE enteropathies in adults.
  • 2016. Selvrapportert matoverfølsomhet.
  • 2016. Matallergi/intoleranse hos voksne.
  • 2016. Kinetics of microbial community composition in patients with diarrhea-predominant irritable bowel syndrome following faecal microbiota transplantation.
  • 2015. The relation between supervisor and candidate.
  • 2015. Kasuistikk. Matvareallergi og matvareintoleranse.
  • 2015. Food hypersensitivity in adults.
  • 2015. Allergic, IgE /non-IgE enteropathies.
  • 2014. The relation between candidate and supervisor.
  • 2014. Subjektiv matoverfølsomhet.
  • 2014. Allergiske, IgE-/non-IgE-enteropatier: Voksne.
  • 2013. Matoverfølsomhet hos voksne.
Popular scientific lecture
  • 2019. Gluten intolerance, food allergy and irritable bowel syndrome.
  • 2015. Food intolerance and gastrointestinal complaints.
  • 2011. A comparison between DSS- and TNBS induced colitis in rats on ultrasonographic intestinal changes: a pilot study.
Academic lecture
  • 2020. Therapeutic Approaches for Dysbiosis.
  • 2020. Kvalitetsevaluering av tverrfaglig IBS-poliklinikk .
  • 2020. Kort- og langtidseffekten av lavFODMAP-diett på symptomer og mikrobiota hos pasienter med IBS .
  • 2019. Non-coeliac gluten sensitivity and the spectrum of gluten-related disorders.
  • 2019. Non-Coeliac Gluten Sensitivity And The Spectrum Of Gluten-Related Disorders: An Updated Overview.
  • 2019. Matallergi og intoleranser.
  • 2019. Mage-tarmskolen – tverrfaglig internetbehandling ved Irritabel tarmsyndrom .
  • 2019. Irritabel bowel syndrome - interdisciplinary treatment options .
  • 2019. Gut microbiota and therapeutic approaches for dysbiosis: Recent developments and future perspectives.
  • 2019. Gut microbiota and therapeutic approaches for dysbiosis.
  • 2019. Effect of faecal microbiota transplantation on gut microenvironment and symptoms in patients with irritable bowel syndrome.
  • 2018. Microbiota 2018.
  • 2018. Is non-celiac gluten sensitivity out?
  • 2018. Fecal Microbiota transplantation.
  • 2017. Microbial DNA markers associated with response to a low FODMAP diet in patients with irritable bowel syndrome.
  • 2017. An overview of potential pathophysiological mechanisms in food hypersensitivity.
  • 2017. An Overview of Gluten-Related Disorders.
  • 2016. Low FODMAP diet alters symptoms, microbiota, short-chain fatty acids and cytokine profiles in patients with IBS: A randomized controlled trial.
  • 2016. Low FODMAP diet alters symptoms, microbiota, short-chain fatty acids and cytokine profiles in patients with IBS: A randomized controlled trial.
  • 2016. Digestive Health - the role of protein nutrition on gut microbiota and the pathogenesis of gastrointestinal disorders?
  • 2015. Intestinal permeabilitet hos friske personer etter inntak av NSAIDs: en pilotstudie.
  • 2013. Veien til doktorgraden: Forskningsveiledning.
  • 2012. Matoverfølsomhet.
  • 2011. Ultrasonographic evaluation of DSS-induced colitis in rats after dietary intake of a modified thia fatty acid.
  • 2010. Potential Role of B Cell-Activating Factor (BAFF) in Non-IgE-mediated Hypersensitivity Reactions to Food.
  • 2009. Potential Role of B Cell-Activating Factor (BAFF) in Non-IgE-mediated Hypersensitivity Reactions to Food.
  • 2009. Indications of `atopic bowel` in patients with irritable bowel syndrome (IBS).
  • 2006. Intestinal Food Hypersensitivity.
  • 2005. Effekt av selolje vs soyaolje på leddsmerter ved inflammatorisk tarmsykdom.
  • 1998. Correlation between intestinal permeability and luminal calprotectin concentration.
Reader opinion piece
  • 2012. Fecal fat excretion in irritable bowel syndrome. Scandinavian Journal of Gastroenterology. 1120-1121.
Short communication
  • 2014. Har silibinin en plass i behandlingen av leversykdommer? Tidsskrift for Den norske legeforening. 392-392.
Masters thesis
  • 2012. Intestinal cleasing and vegan diet as a novel modality for treatment of irritable bowel syndrome (IBS).
  • 2005. Acute effects of duodenal seal oil or soy oil administration on gastric accommodation and symptoms in patients with food hypersensitivity.
Popular scientific article
  • 2018. Lav FODMAP-diett for pasienter med stråleskadet tarm. NGF-nytt. 30-32.
  • 2017. Ikke-cøliakisk gluten sensitivitet. NGF-nytt. 24-25.
Doctoral dissertation
  • 2020. Health effects of supplementation with cod protein hydrolysate: Impact on glucose metabolism and appetite in healthy subjects and gut health in irritable bowel syndrome.
  • 2013. Subjective food hypersensitivity: Studies on enterochromaffin cell secretion products and effects of seal oil therapy.
  • 2010. Subjective food hypersensitivity: Lifestyle and psychological factors.
  • 2010. Self-reported food hypersensitivity with gastrointestinal symptoms. Allergological and psychological factors.
Interview
  • 2020. Kronprins Haakons forskningspris til Haukelandforsker.
  • 2020. Forskningsprisvinner er ledende på matallergi og intoleranser.
  • 2020. Eksperter kaller matintoleranse­tester for svindel. Ina (26) fikk påvist intoleranse hun ikke hadde.
  • 2020. Astma- og allergipris til Gülen Arslan Lied.
  • 2019. Probiotika kan hjelpe på magetrøbbel.
  • 2019. Probiotika kan hjelpe på magetrøbbel.
  • 2019. IBS-pasienter ble bedre i magen etter bæsj-transplantasjon.
  • 2018. Nina Kristiansen utelater et viktig budskap om vår forskning på glutensensitivitet.
  • 2018. Mente selv at de ikke tålte gluten, men ble ikke verre av å spise gluten.
  • 2018. Glutenstøtten kan bli kraftig redusert.
  • 2016. Studerte placebo-effekten ved kosthold.
  • 2015. Slik får du fart på magen.
  • 2014. Spesialistfront mot allergi.
  • 2014. Karrierevegar sentralt på Orpheus-konferansen 2014.
  • 2012. Matallergi. Diagnostisk manuel for voksne (DM voksen).
Academic chapter/article/Conference paper
  • 2013. alfa-gal-allergi (kjøttallergi). 3 pages.
  • 2013. Matintoleranse og allergi i gastrointestinaltraktus. 3 pages.
Abstract
  • 2018. Interdisciplinary self- help intervention for IBS - eHealth and patient education. Neurogastroenterology and Motility. 182-183.
  • 2018. Effects of faecal microbiota transplantation on gut microenvironment and symptoms in patients with irritable bowel syndrome. Neurogastroenterology and Motility. 178-179.
  • 2017. The effect of a controlled gluten challenge in patients with suspected non-coeliac gluten sensitivity: A randomized, double-blind placebo-controlled challenge. Clinical Nutrition. 32-33.
  • 2017. Microbial DNA markers associated with response to a low FODMAP diet in patients with irritable bowel syndrome. Gastroenterology. S-44-S-45.
  • 2017. Low FODMAP diet improves symptoms and quality of life in patients with radiation-induced small bowel disease: A pilot study. Neurogastroenterology and Motility. 70-71.
  • 2017. Low FODMAP diet improves symptoms and quality of life in patients with radiation-induced small bowel disease: A pilot study. Clinical Nutrition. 207-208.
  • 2017. Gluten causes symptom relapse in a small group of patients with suspected non-celiac gluten sensitivity: A randomized, double-blind placebo controlled challenge. Neurogastroenterology and Motility. 68-69.
  • 2017. Effect of faecal microbiota transplantation on the symptoms and gut microbiota in patients with irritable bowel syndrome (IBS). Neurogastroenterology and Motility. 73-74.
  • 2017. Effect of faecal microbiota transplantation on gut bacterial fermentation products in patients with irritable bowel syndrome. United European Gastroenterology journal. A563-A564.
  • 2017. Effect of faecal microbiota transplantation on Neurogenin 3, Musahsi 1 and enteroendocrine cells in the duodenum of patients with irritable bowel syndrome. United European Gastroenterology journal. 785-786.
  • 2016. The Gastric Accomodation Reflex Studied by Ultrasound, Manometry and Impedancemetry in a Pilot Study. United European Gastroenterology journal. 675-675.
  • 2016. Low FODMAP diet alters symptoms, microbiota, short-chain fatty acids and cytokine profiles in patients with IBS: A randomized controlled trial. United European Gastroenterology journal. A101-A101.
  • 2016. Kinetics of microbial community composition in patients with diarrhea-predominant irritable bowel syndrome following faecal microbiota transplantation. United European Gastroenterology journal. LB11-LB11.
  • 2016. High levels of serum total IgE-antibodies are not related to intestinal and extra-intestinal symptom severity in irritable bowel syndrome. Neurogastroenterology and Motility. 63-63.
  • 2016. Effect of fecal microbiota transplantation on the symptoms and duodenal enteroendocrine cells in patients with irritable bowel syndrome. United European Gastroenterology journal. 677-677.
  • 2015. Atopic sensitization and functional gastrointestinal symptoms: Is there any relation? Gastroenterology. 778.
  • 2014. Are total immunoglobulin E and atopic sensitization associated with food-related gastrointestinal complaints? Neurogastroenterology and Motility. 42.
  • 2010. Dendritic cell populations in patients with self-reported food hypersensitivity. Gut. A394.
  • 2009. Potential role of B-cell activating factor in non-IgE-mediated hypersensitivity reactions to food. Gut. A116-A116.
  • 2009. Indications of `atopic bowel` in patients with irritable bowel syndrome (IBS). Neurogastroenterology and Motility. 7-7.
  • 2009. Indications of "atopic bowel" in patients with irritable bowel syndrome. Gut. A20-A20.
  • 2008. Cross-sectional study on the correlation between pre-operative azathioprine and myenteric plexitis in the proximal resection margins and affected Crohn's disease segment. Gastroenterology. 687-687.
  • 2004. Calprotectin in faeces and gut lavage fluid; relationship to intestinal permeability and disease activity in IBD. Scandinavian Journal of Gastroenterology. 8-8.
  • 2003. Subjective health complaints and quality of life in patients with self-reported adverse reactions to food. Scandinavian Journal of Gastroenterology, Supplement. 15-15.
  • 2003. Seal oil compared to soy oil in patients with inflammatory bowel disease. Gastroenterology. 67-67.
Poster
  • 2019. Quantified Mucosal Gut Health: hiding in plain sight.
  • 2019. Evaluation of a tertiary, multidisciplinary outpatient clinic for irritable bowel syndrome.
  • 2019. Evaluation of a tertiary, multidisciplinary outpatient clinic for irritable bowel syndrome.
  • 2019. Brain-Gut-Microbiota Interaction in Irritable Bowel Syndrome: A Multidimensional Approach .
  • 2018. The effect of a cod protein hydrolysate on postprandial glucose metabolism in healthy subjects.
  • 2018. Effects of faecal microbiota transplantation on gut microenvironment and symptoms in patients with irritable bowel syndrome.
  • 2018. Correlations between gut microenvironment and symptoms in patients with diarrhea-predominant irritable bowel syndrome.
  • 2017. The effect of a controlled gluten challenge in patients with suspected non-coeliac gluten sensitivity: A randomized, double-blind placebo-controlled challenge.
  • 2017. Low FODMAP diet improves symptoms and quality of life in patients with radiation-induced small bowel disease: A pilot study.
  • 2017. Effect of faecal microbiota transplantation on gut bacterial fermentation products in patients with irritable bowel syndrome.
  • 2017. Effect of faecal microbiota transplantation on Neurogenin 3, Musahsi 1 and enteroendocrine cells in the duodenum of patients with irritable bowel syndrome.
  • 2016. Low versus high FODMAP diet in patients with irritable bowel syndrome.
  • 2016. Low FODMAP diet – just placebo? Low versus high FODMAP diet in patients with irritable bowel syndrome.
  • 2016. Low FODMAP diet alters symptoms, microbiota, short-chain fatty acids and cytokine profiles in patients with IBS: A randomized controlled trial.
  • 2014. The Role of Research Supervision on Doctoral Degree.
  • 2012. Intestinal cleansing and vegan diet as a novel modality for treatment of irritable bowel syndrome (IBS).
  • 2010. Potential role of B-cell activating factor (BAFF) in non-IgE-mediated hypersensitivity reactions to food.
  • 2010. Do psychological factors explain symptom severity in patients with subjective food hypersensitivity?
  • 2009. Potential role of B-cell activating factor in non-IgE-mediated hypersensitivity reactions to food.
  • 2009. Indications of "atopic bowel" in patients with irritable bowel syndrome.
Errata
  • 2019. Effect of a cod protein hydrolysate on postprandial glucose metabolism in healthy subjects: A double-blind cross-over trial - CORRIGENDUM. Journal of Nutritional Science (JNS). 1-2.
Academic literature review
  • 2020. Gut Microbiota and Therapeutic Approaches for Dysbiosis in Irritable Bowel Syndrome: Recent Developments and Future Perspectives. 1-29.
  • 2020. Effects of Plant-Based Diets on Outcomes Related to Glucose Metabolism: A Systematic Review. 2811-2822.
  • 2019. Probiotics in irritable bowel syndrome: An up-to-date systematic review. 1-15.
  • 2018. Non-coeliac gluten sensitivity and the spectrum of gluten-related disorders: an updated overview. 1-10.
  • 2017. An overview of potential pathophysiological mechanisms in food hypersensitivity. 16-17.
  • 2014. Spekter av gluten-relaterte lidelser. 30-31.
  • 2014. Immunsystemets rolle ved selvrapportert matoverfølsomhet. 12-15.
  • 2011. Perceived food hypersensitivity: A review of 10 years of interdisciplinary research at a reference center. 1169-1178.
  • 2011. Pasienten tåler ikke mat - hva skal vi tro? 36-40.
  • 2011. Matoverfølsomhet- Et paradigmeskifte? 30-33.
  • 2011. Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review. 1-7.
  • 2009. Matoverfølsomhet og funksjonelle mage-tarmsykdommer: Hvilke punkter er viktige ved første konsultasjon? 18-23.
  • 2007. Gastrointestinal food hypersensitivity: Symptoms, diagnosis and provocation tests. 5-13.
  • 1999. Intestinal allergi. 10-12.
Article in business/trade/industry journal
  • 2017. Nutrition, health and chronic diseases. Indremedisineren. 16-18.
  • 2015. Matoverfølsomhet - den nye folkesykdommen? Bioingeniøren. 16-17.
  • 2015. An overview of spectrum of gluten-related disorders. Güncel Gastroenteroloji (Turky). 87-90.
Interview Journal
  • 2019. Matvareoverfølsomhet og -allergi. LMF.

More information in national current research information system (CRIStin)